; and (3) encourage access to non-opioid alternatives when medically appropriate. (b) Prohibition on requiring fail first schemes The Secretary shall prohibit a group health plan and a health insurance issuer offering group or individual health insurance coverage from requiring fail first schemes, also known as step therapy, with respect to abuse-deterrent opioids. (c) Abuse-Deterrent opioid defined In this section, the term abuse-deterrent opioid means an abuse-deterrent formulation of an opioid, as determined by the Secretary. . (3) Effective date The amendments made by this subsection shall apply with respect to plan years beginning on or after January 1, 2019. (b) Educational outreach The Secretary of Health and Human Services shall educate health insurance issuers, Medicare Advantage plans under part C of title XVIII of the Social Security Act ( 42 U.S.C. 1395w–21 et seq.), and prescription drug plans under part D of such title ( 42 U.S.C. 1395w–101 et seq.) on opioid abuse prevention, including the use of abuse-deterrent opioids (as such term is defined in section 2729 of the Public Health Service Act, as added by subsection (a)(2)). 18. Grant program to provide support for medication assisted treatment (a) Training grants The Secretary of Health and Human Services shall award grants to States for the purpose of training non-physician health care professionals in the use of medication-assisted treatment approved by the Food and Drug Administration and related best practices. (b) Referral system grants The Secretary of Health and Human Services shall award grants to States for the purpose of improving referral systems and ensuring that such systems are current and accurate, in order to better enable practitioners to refer patients who are prescribed medication assisted treatment to cognitive therapy. 19. Sobriety Treatment and Recovery Teams (START) Title III of the Comprehensive Addiction and Recovery Act of 2016 ( Public Law 114–198